ACTA2 and chronic kidney disease: Although some enrichment for osteoblast differentiation in the CKD patient biopsies was observed using RNAseq, no reduction was observed in the expression of the classical VSMC differentiation, such as ACTA2, MYH11, and TAGLN using qRT-PCR.